
Ammar Al-Chalabi
@ammaralchalabi
Professor of Neurology and Complex Disease Genetics, King's College London Co-Director UK MND Research Institute MND ALS Specialist. @ammaralchalabi.bsky.social
ID: 4059872218
https://en.m.wikipedia.org/wiki/Ammar_Al-Chalabi 28-10-2015 09:58:22
4,4K Tweet
4,4K Followers
4,4K Following


The results of the MIROCALS trial are published! Proud to be part of this massive effort. May is ALS Awareness Month, and what a powerful reminder that science works, people with #ALS #MND matter, and breakthroughs are possible. Hoping for approval soon! sciencedirect.com/science/articl…


People with SOD1 #MND deserve access to life-changing treatment. As Chair of the APPG on Motor Neurone Disease I am supporting the call to make tofersen available now. ✍️ Sign the petition here: act.mndassociation.org/2025-prescribe… #PrescribeLife

Tofersen is a ground-breaking treatment for people with SOD1 #MND, 2% of those with MND But not everyone can access it & time is critical As vice-chair of the APPG on Motor Neurone Disease I am backing the call to improve access✍️ Sign the petition here: act.mndassociation.org/2025-prescribe… #PrescribeLife

A happy occasion for the family today as my sister presented and defended her PhD research UCL Queen Square Institute of Neurology. Congratulations on an outstanding performance. You made us proud! #PhD #als





The UK MND Research Institute have published their latest findings from the MND Register, showcased at the 2025 ENCALS meeting in Turin, Italy. 🧬#MND

Oxford MND Research Lizzie Dellar "Expert reaction to study looking at the association between prescribed use of common psychiatric medications and the risk and progression of amyotrophic lateral sclerosis (ALS) aka motor neuron disease (MND)..." - Science Media Centre UK Ammar Al-Chalabi Brian Dickie

Fernando de Castro S H. N. Parapléjicos Fundación CIEN FundaciónRamónAreces Por Cajal y la Ciencia Eduardo Weruaga Estanislao Nistal Villán Guglielmo Foffani Arantxa Tabernero INCYL IBSAL SENC David Ezpeleta TecnoSEN Alberto J. S. Fundación Cotec Antonio Arias Rodríguez JR Chaves 7 lagos, 7 vidas Dr.sara_squarechesnut y Estanislao Nistal Villán veo colaboración con Ammar Al-Chalabi Es un fenómeno.


Ayer tuve el honor de acompañar a la Reina Doña Sofía Casa de S.M. el Rey en la clausura del II Congreso de ELA Manolo Barrós, espacio clave para mostrar la necesidad de investigar y avanzar en la prevención y tratamiento de ELA Comunidad de Madrid Ammar Al-Chalabi Fundación CIEN #ciencia #ELA


🚨 We’re proud to be the principal funder of the £7.5M Longitude Prize on ALS - a global challenge aiming to accelerate drug discovery for ALS/MND using AI and one of the world’s largest patient data sets. The prize is designed and delivered by Challenge Works and backed by


trisdyson Martin Rees Lucy Hawking Dr Usman Khan MND Association Michael Peel hosts our panel discussion with Lucinda Scharff, Ammar Al-Chalabi, Nicole Stone and Gopuraja Dharmalingham all about the potential of the Prize and how important quality data is in finding new treatment options


🚨 In case you missed it: King’s team featured on BBC Breakfast as part of the launch of the Longitude Prize on ALS a £7.5M challenge to harness AI & big data for discovering new treatments for ALS/MND. Huge potential for impact! 💡🧠💊 #MND #AI #DrugDiscovery

Inspiring evening at launch of Longitude Prize on ALS Challenge accepted: combine AI, biology & clinical data to fast track drug discovery for Motor Neurone Disease Dr Usman Khan Martin Rees Lucinda Scharff Lucy Hawking Michael Peel Ammar Al-Chalabi trisdyson MND Association


Translation: "Yesterday, I had the honor of accompanying Queen Doña Sofía Casa de S.M. el Rey at the closing of the II Manolo Barrós #ALS/#MND/#ELA Congress, a key space to highlight the need to research and advance in the prevention and treatment of #ALS/#MND/#ELA Comunidad de Madrid

Martin Rees Lucy Hawking Plus more from Dr Usman Khan, Marc Barlow and a panel discussion hosted by Michael Peel with Lucinda Scharff, Ammar Al-Chalabi, Nicole Stone and Gopuraja Dharmalingham on the potential of the Longitude Prize on ALS

